Today: 10 June 2026
Coinbase stock slips after-hours as Bitcoin dips and BofA’s $340 call meets new copper futures plan
10 January 2026
1 min read

Coinbase stock slips after-hours as Bitcoin dips and BofA’s $340 call meets new copper futures plan

New York, January 9, 2026, 18:01 EST — After-hours

Coinbase Global, Inc. shares slipped 1.9% in after-hours trading on Friday to $240.78, after ranging between $237.27 and $248.20 during the session. Bitcoin was down 0.8% near $90,486 and ether fell 1.2%, keeping pressure on crypto-linked stocks into the close.

The moves come as investors weigh whether Coinbase can lean less on crypto spot trading, which can cool fast when prices fall. The company has started pushing into stock trading and event contracts — wagers on real-world outcomes — in a bid to pull more of retail trading under one roof, competing with brokers such as Robinhood and Interactive Brokers.

Bank of America upgraded Coinbase to “buy” on Thursday and maintained a $340 price target, citing faster product rollouts and what it called a stock pullback of about 40% from July highs. Analyst Craig Siegenthaler said the firm turned positive “post 2H product velocity acceleration and stock pullback,” and pointed to Base — Coinbase’s Ethereum layer-2 network, which processes transactions on top of Ethereum to cut costs — as central to the build-out. Investing.com

A Commodity Futures Trading Commission filing dated Jan. 8 showed Coinbase Derivatives submitted changes to its non-crypto market maker program that “will become effective on trade date January 26, 2026.” The filing lists copper and platinum futures alongside nano crude oil, gold, silver and natural gas contracts — futures are agreements to buy or sell an asset at a set price on a future date. CFTC

Coinbase’s December product update laid out a broader “everything exchange” pitch, including a rollout of U.S. stock trading and prediction markets in its main app, plus a simplified interface for futures and perpetual futures, known as perps — contracts that track an underlying price without an expiry date. The company also flagged plans for 24/5 stock trading and a new “Coinbase Tokenize” platform aimed at tokenising real-world assets for institutions. Coinbase

But Coinbase still trades like a geared bet on crypto sentiment, and that can swamp product news in the short run. A deeper slide in bitcoin or a hit to retail risk appetite would likely pressure trading volumes and fee revenue, while newer lines such as commodities futures and event contracts may take time to build liquidity.

Traders will watch whether copper and platinum futures go live as planned on Jan. 26 and whether Coinbase offers more detail on the timing of its broader equities push. Earnings calendars tracked by Zacks expect Coinbase’s next quarterly report around Feb. 12, though the company has not confirmed a date.

Stock Market Today

  • U.S. Stock Futures Fall Amid Iran Strikes and Inflation Concerns
    June 10, 2026, 9:04 AM EDT. Nasdaq futures declined over 1% as former President Donald Trump warned of further actions against Iran following recent strikes. Investors also braced for upcoming Consumer Price Index (CPI) data, with economists forecasting inflation to surpass a critical threshold. The developments heightened market jitters, impacting investor sentiment ahead of key economic releases.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Previous Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next
Next Story

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Go toTop